What long-term monitoring is indicated in pediatric atopic dermatitis (AD)?

Updated: Apr 26, 2021
  • Author: Robert A Schwartz, MD, MPH; Chief Editor: Dirk M Elston, MD  more...
  • Print

Frequent follow-up is needed early in the course of atopic dermatitis (AD) to ensure compliance and assess patient responsiveness to therapy. Analyze treatment failures for the presence of resistant organisms, contact dermatitis to a medication (eg, preservatives in steroid preparations, bacitracin), or parental noncompliance.

There is no evidence to date that AD is an independent risk factor for acquiring coronavirus disease 2019 (COVID-19) or having it with enhanced severity, at least in adults. [52]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!